Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT02248831 · ClinicalTrials.gov registry record · NA
Evaluation of Cardiopulmonary Diseases by Ultrasound
A NA study of Dyspnea and Acute Decompensated Heart Failure, sponsored by Echosense.
- Completed
- Registry status
- NA
- Development phase
- 600
- Enrollment target
- 1
- Study location
NCT02248831 is a NA study of Dyspnea and Acute Decompensated Heart Failure that has completed, run by Echosense. The registered enrollment target is 600 participants, above the 279-participant average among 23 other Dyspnea trials with a reported enrollment target (115% higher). The trial reports 1 study location across 1 state.
The verdict
NCT02248831, a NA study of Dyspnea and Acute Decompensated Heart Failure, has completed, sponsored by Echosense.
- COMPLETED
- Registry status
- NA
- Development phase
- 600 participants
- Enrollment target
- 1
- Study location
Study Summary
Historically, ultrasound imaging of the lung parenchyma has been challenging because of the high total ultrasound energy attenuation and scattering by the air in the lungs. However, recent technological advancements have allowed for rapid assessment of various pulmonary diseases via the use of lung ultrasound. Furthermore, it has been shown that clear reproducible Doppler signals can be recorded from the lung parenchyma by means of a pulsed Doppler ultrasound system incorporating a special signal-processing package. The LDS may contain information of significant diagnostic and physiological value regarding the pulmonary parenchyma and vasculature, as well as the cardio-vascular system in general. In a pilot clinical validation study of patients with acute decompensated heart failure (ADHF) patients, LDS signals unique to ADHF patients were identified, that superpose on the normal Lung Doppler Signals (unpublished data). These are high velocity "disorganized" variable signals that are not synchronous with the cardiac cycle but rather sometimes with respiration.
Conditions Studied
Interventions
- DEVICE Recording Doppler ultrasound signals noninvasively
Study Locations (1)
Massachusetts
- Emergency Medicine department and Inpatients floors,MGH - Boston
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 600 participants |
| Start Date | 2014-09 |
| Est. Completion | 2018-12 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT02248831
The ClinicalTrials.gov registry entry for NCT02248831 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 600 participants, a figure that helps gauge the scale of data the investigators plan to collect, above the 279-participant average among 23 other Dyspnea trials with a reported enrollment target (115% higher). The listed sponsor is Echosense, which has 6 total studies on file at ClinicalTrials.gov.
The record links to 2 conditions, with Dyspnea appearing as the primary indexed condition, and to 1 intervention - of which Recording Doppler ultrasound signals noninvasively is the first listed.
NCT02248831 reports 1 study location spanning 1 distinct geographic area - top geographies include Massachusetts.
Frequently Asked Questions
What is clinical trial NCT02248831 about?
NCT02248831 is a clinical study titled "Evaluation of Cardiopulmonary Diseases by Ultrasound". Historically, ultrasound imaging of the lung parenchyma has been challenging because of the high total ultrasound energy attenuation and scattering by the air in the lungs. However, recent technological advancements have allowed for rapid assessment of various pulmonary diseases via the use of lung ...
What is the current status of trial NCT02248831?
This trial is currently completed. It is a NA study. The enrollment target is 600 participants. The study started on 2014-09. Estimated completion is 2018-12.
What conditions does trial NCT02248831 study?
This clinical trial studies the following conditions: Dyspnea, Acute Decompensated Heart Failure.
What interventions are being tested in trial NCT02248831?
The interventions under investigation include: Recording Doppler ultrasound signals noninvasively (DEVICE).
Who is sponsoring clinical trial NCT02248831?
This trial is sponsored by Echosense, which has 6 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT02248831 being conducted?
This trial has 1 study location across Massachusetts. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Dyspnea
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
-
The Increase of Lung Capacity Using the Lung Master (Pulmonary Exerciser)
RECRUITING · NA
-
Inspiratory Muscle Training for Breast Cancer Patients on Chemotherapy
RECRUITING · NA
-
Breathlessness Relieved by Employing Medical Air to be Titrated by Hospitalized Patients to Improve Inpatient Experience
ACTIVE NOT RECRUITING · NA
-
Improving Management of Breathlessness in Patients With Lung Cancer
COMPLETED · NA
-
Oxygen Savings With Administered Oxygen and High Flow Ambient Air At Rest
COMPLETED · NA
-
Evaluation of Breathing Pattern and Dyspnea in Subjects With Tetraplegia
COMPLETED · NA
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.